Insiders Nektar Therapeutics

Equities

NKTR

US6402681083

Real-time Estimate Cboe BZX Other stock markets 18:02:45 09/05/2024 BST			5-day change	1st Jan Change
1.655 ^USD	+0.91%		-0.30%	+194.69%

04-24	Biolojic Design Announces Nektar Therapeutics Exercised Its License Option to Develop an AI-Designed Agonistic Antibody Targeting TNFR2 for the Treatment of Autoimmune Diseases	CI
03-19	Nektar Therapeutics announced that it has received $30 million in funding from TCG Crossover Management, LLC	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

DiaMedica Therapeutics Names Lorianne Masuoka as Chief Medical Officer	01-22	MT
Nektar Therapeutics to Cut Staff, Reprioritize Projects in Cost Cutting Plan	18/04/23	MT
Nektar Therapeutics Announces Management Changes	17/04/23	CI
Karin Eastham Announces Not to Stand for Re-Election to the Board of Nektar Therapeutics	11/04/23	CI
Insider Sell: Nektar Therapeutics	22/08/22	MT
Nektar Therapeutics Promotes Jillian Thomsen to CFO	01/07/22	MT
Nektar Promotes Jillian B. Thomsen to Senior Vice President	01/07/22	CI
John Northcott Step Down as Senior Vice President and Chief Commercial Officer of Nektar Therapeutics	25/04/22	CI
Nektar Therapeutics Strengthens Board of Directors with Appointment of Diana M. Brainard, M.D	15/11/21	CI
Insider Sell: Twist Bioscience	25/10/21	MT
Insider Trends: Insider Prolongs 90-Day Selling Trend at Nektar Therapeutics	19/08/21	MT
Insider Trends: Nektar Therapeutics Insider Extends 90-Day Selling Trend	19/08/21	MT
Insider Trends: Selling By Insiders Lingers at Nektar Therapeutics	19/08/21	MT
Insider Trends: Selling By Insiders Lingers at Nektar Therapeutics	19/08/21	MT
Nektar Therapeutics Appoints Dimitry S.A. Nuyten as Senior Vice President and Chief Medical Officer	19/07/21	CI
Insider Trends: Insider 90-Day Selling Trend Extended at Nektar Therapeutics	20/05/21	MT
Insider Trends: Insider Adds to Selling Trend at Nektar Therapeutics	20/05/21	MT
Insider Trends: Nektar Therapeutics Insider Continues 90-Day Selling Trend	20/05/21	MT
Insider Trends: Nektar Therapeutics Insider Extends 90-Day Selling Trend	20/05/21	MT
Insider Trends: Nektar Therapeutics Insider Extends 90-Day Selling Trend	20/05/21	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Nektar Therapeutics

Equities

NKTR

US6402681083

Insiders

Filters